Patients with symptomatic azole-resistant Candida albicans or non-albicans candida are difficult to manage. Treatment is largely anecdotal due to the relatively small number of patients. We present six case reports which highlight our own observation in clinical practice including four patients who were treated successfully with topical amphotericin B/flucytosine vaginal gel for 14 days (Stoke-on-Trent formula).
United Kingdom National Guideline on the Management of Vulvovaginal Candidiasis (2007). See http://www.bashh.org (last accessed 15 May 2012)
2.
BinghamJS. What to do with the patient with recurrent vulvovaginal candidiasis. Sex Transm Inf1999;75:225–7
3.
GeigerAM, FoxmanB, SobelJD. Chronic vulvovaginal candidiasis: characteristics of women with Candida albicans, C glabrata and no candida. Genitourin Med1995;71:304–7
4.
WhiteDJ, JohnsonEM, WarnockDW. Management of persistent vulvovaginal candidosis due to azole-resistantCandida glabrata. Genitourin Med1993;69:112–4
5.
WhiteDJ, HabibAR, VanthuyneA, Combined topical flucytosine and amphotericin B for refractory vaginal Candida glabrata infections. Sex Transm Inf2001;77:212–3
